中文
| Catalogue |
|
|
| Recommend Products |
APEIRON Biologics AG
Australia, Manufacturer, Hits: 1188, Updated:1/8/2018
Campus-Vienna-Biocenter 51030 Vienna |
Company Profile
-
Apeiron is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. Recently, the most advanced program, an antibody-based immunotherapy to treat neuroblastoma, was granted marketing approval in the EU. The company is developing additional immunotherapies, predominantly in clinical stage, based either on targeted, tumor-specific approaches or on the stimulation of the immune system via novel and proprietary modes of action (unique checkpoint blockade mechanisms) to fight cancer by engaging the human body’s natural defense mechanisms. For additional information please go to www.apeiron-biologics.com and follow us on Twitter @apeironbio.
Company News
- APEIRON Biologics Commences Clinical COVID-19 Trial with Inhaled APN01 10/12/2021
- APEIRON Biologics Announces Changes to Management and Supervisory Boards 6/2/2021
- APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19 4/2/2020
- APEIRON Starts Pilot Clinical Trial on it's Respiratory Drug to Treat COVID-19 Coronavirus Disease 2/26/2020
- APEIRON to Present Clinical Data on Two Immunotherapy Programs 5/31/2018
- APEIRON to Present at the Biotech Showcase™ Annual Conference 1/8/2018